All News     |   Press Releases     |   Newsletters     |   Blog

News

Read all of the latest news, press releases, newsletters, and blog posts. Choose a link above to filter by category.

    • 13 AUG 15
    • 0

    Lattice Biologics Announces Proposed Merger with Blackstone Ventures

    August 13, 2015 NEWS RELEASE Lattice Biologics Inc. (“Lattice”) is pleased to announce that it has entered into a letter of intent (the “LOI”) with Blackstone Ventures Inc. (“Blackstone”) (TSX‐V: BLV), a company listed on the TSX Venture Exchange. Pursuant to the LOI, Blackstone is proposing to acquire all of the issued and outstanding securities of Lattice (the “Transaction”).

    Read more →
    • 11 AUG 15
    • 0

    Lattice Biologics’ New Toronto Office

    Aug 11, 2015 Going to be in the Toronto area? Come visit us! Lattice Biologics is thrilled to announce the opening of our newest office at 181 University Ave., Toronto Ontario.  As a Scottsdale Arizona firm, we have been overwhelmed by the incredibly supportive relationships we have enjoyed across the Canadian border. We could not be

    Read more →
    • 22 JUN 15
    • 0

    Lattice Biologics Newsletter 2: Funding and Initiatives for Personalized Medicine

    Jun 22, 2015 All across the globe, government and industry support is gaining incredible momentum for the science and technologies of precision/personalized medicine, stem cell research, and regenerative medicine.  And for many excellent reasons.  Advances in these areas in the United States, Canada, and beyond are changing and saving lives every day.  #PersonalizedMedicine #LatticeBiologics Check out our latest newsletter

    Read more →
    • 20 JUN 15
    • 0

    In case you missed it: the first Lattice Biologics newsletter

    Jun 24, 2015 Covering news and advancements in personalized medicine, precision medicine, and regenerative medicine and our progress in cellular therapies and tissue engineering. Taking Arizona Biomedical products to international markets. Read on here and subscribe. Issue 1: Big Developments for Regenerative Medicine: The World Stem Cell Conference, Canadian Burn Symposium, Phoenix Business Journal, Yahoo! Finance and more. ______

    Read more →
    • 03 JUN 15
    • 0

    $1M capital infusion for Scottsdale cell therapy co. Lattice Biologics

    Phoenix Business Journal Jun 3, 2015 Lattice Biologics, Inc. has been up to big things lately. See the article here: Phoenix Business Journal article Also check out our article on Yahoo! Finance. Click here to sign-up to receive our newsletter for updates in funding, technologies, and advancements in medical bioscience.  We would love to keep you

    Read more →
    • 21 MAY 15
    • 0

    Scottsdale Cell Therapy Firm Lattice Biologics Lands $1M Capital Infusion

    Phoenix Business Journal May 21, 2015, 11:21am MST Scottsdale-based Lattice Biologics Inc. just got $1 million from Grenville Strategic Royalty Corp. (TSX VENTURE: GRC). This brings Grenville’s total Lattice investment to $3 million, said Guy Cook, CEO of Lattice Biologics, which focuses on cellular therapies and tissue engineering. The Toronto-based firm had invested $2 million in Lattice last September. In exchange for

    Read more →
    • 11 MAY 15
    • 0

    Grenville Completes Follow-On Investment in Lattice Biologics

    Grenville Strategic Royalty Corp. May 11, 2015 2:00 PM TORONTO, ONTARIO – (Marketwired – May 11, 2015) Grenville Strategic Royalty Corp. (TSX VENTURE:GRC) (“Grenville”) is pleased to announce that it has advanced an additional USD$1,000,000 to Lattice Biologics Inc. (“Lattice Biologics”). This investment represents Grenville’s first follow-on investment in Lattice Biologics and brings Grenville’s total investment in Lattice Biologics to USD$3,000,000.

    Read more →
    • 19 MAR 15
    • 0

    Emergent Technology: World Stem Cell Conference

    Mar 19, 2015 Next week Lattice Biologics will present “Extracellular Matrix-Assisted Cell Viability” at the 5th World Conference on Cell & Stem Cell Research (Stem Cell Therapy-2015) in Chicago, March 23-25. Our work in emergent adult stem cell therapy technology is leading to the “next generation of allografts.” These treatments will offer true regenerative solutions

    Read more →

Recent Events